NCT05741619View on ClinicalTrials.gov

Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis.

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 1, 2022

Study Completion Date

September 1, 2022

Conditions
Autoimmune Encephalitis
Interventions
OTHER

Long-term outcome

Autonomy, physical examination, behavioural disorders

Trial Locations (1)

69677

Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT05741619 - Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis. | Biotech Hunter | Biotech Hunter